Allspring Global Investments’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-929
| Closed | -$5.15K | – | 1925 |
|
|
2024
Q3 | $5.15K | Sell |
929
-24,215
| -96% | -$134K | ﹤0.01% | 2178 |
|
|
2024
Q2 | $140K | Buy |
+25,144
| New | +$140K | ﹤0.01% | 1792 |
|
|
2023
Q4 | – | Sell |
-4,803
| Closed | -$26.5K | – | 2330 |
|
|
2023
Q3 | $26.5K | Sell |
4,803
-3,096
| -39% | -$17.1K | ﹤0.01% | 2439 |
|
|
2023
Q2 | $67.5K | Buy |
7,899
+1,837
| +30% | +$15.7K | ﹤0.01% | 2194 |
|
|
2023
Q1 | $55.7K | Buy |
6,062
+1,199
| +25% | +$11K | ﹤0.01% | 2248 |
|
|
2022
Q4 | $49.7K | Sell |
4,863
-214
| -4% | -$2.19K | ﹤0.01% | 2322 |
|
|
2022
Q3 | $74K | Buy |
5,077
+1,789
| +54% | +$26.1K | ﹤0.01% | 2189 |
|
|
2022
Q2 | $35K | Sell |
3,288
-17,186
| -84% | -$183K | ﹤0.01% | 2350 |
|
|
2022
Q1 | $220K | Buy |
20,474
+1,270
| +7% | +$13.6K | ﹤0.01% | 2541 |
|
|
2021
Q4 | $313K | Buy |
+19,204
| New | +$313K | ﹤0.01% | 2487 |
|